Milos Pekny

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Ludwig Institute for Cancer Research Limited, Other. Active years: 2001-2022.

USPTO Granted Patents = 2

% Patents Active = 100.0

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 4.2

ph-index = 1

Forward Citations = 12(Granted Patents)

Company Filing History:

1 out of 530

Ludwig Institute for Cancer Research Limited

patents

1 out of 834,411

Other

patents

Years Active: 2001-2022

Loading Chart...

2 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11266715 - C3A receptor agonists for use against ischemic brain injury, stroke, traumatic brain injury, spinal cord injury and neurodegenerative disorders (2022-03-08),

2. 6262337 - Transgenic animal with recombinant vascular endothelial growth factor B (VEGF-B DNA) and uses thereof (2001-07-17),

Profile summary based on public USPTO records.

Please report any incorrect information to [email protected]

1 patent (EPO):

Please report any incorrect information to [email protected]

1 patent pending (EPO):

Please report any incorrect information to [email protected]